Stromal tumor infiltrating lymphocytes and TNBC-DX provide complementary prognostic information in triple-negative breast cancer

Journal:

Journal of the National Cancer Institute

Published:

2025-07-02

DOI:

10.1093/jnci/djaf162

Affiliations:

24

Authors:

28

Go to article

Institutions	Authors	Share
Reveal Genomics, S.L., Spain	4.916667	0.18
University of Kansas Medical Center (KUMC), United States of America (USA)	4.800000	0.17
Gregorio Marañon University Hospital, Spain	3.616667	0.13
Investigación Sanitaria del Hospital Gregorio Marañón (IISGM), Spain	3.616667	0.13
August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Spain	1.916667	0.07
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Spain	1.783333	0.06
Spanish Research Group on Breast Cancer (GEICAM), Spain	1.783333	0.06
Hospital Infanta Cristina, Spain	1.000000	0.04
Health Research Institute of San Carlos (IdISSC), Spain	1.000000	0.04
National Institute of Neoplastic Diseases (INEN), Peru	1.000000	0.04
GZA-ZNA Antwerp, Belgium	0.500000	0.02
Peter MacCallum Cancer Centre (Peter Mac), Australia	0.500000	0.02
SOLTI Breast Cancer Research Group, Spain	0.450000	0.02
Vall d'Hebron University Hospital (HUVH), ICS, Spain	0.250000	0.01
The University of Texas MD Anderson Cancer Center, United States of America (USA)	0.200000	0.01
Hospital Clinic of Barcelona, Spain	0.166667	0.01
University of Barcelona (UB), Spain	0.166667	0.01
IOB Institute of Oncology, Spain	0.166667	0.01
Quirónsalud, Spain	0.166667	0.01

Interested in Oncology and Carcinogenesis?